NFATC2 and breast carcinoma: The findings suggest that TRPV6 activation enhances NFATc2’s transcriptional activity by modulating the phosphorylation of NFATc2IP, thereby promoting ADAMTS6 expression and facilitating metastasis in breast cancer.